Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.440
+0.060 (4.35%)
At close: Jan 2, 2026, 4:00 PM EST
1.434
-0.006 (-0.45%)
After-hours: Jan 2, 2026, 6:42 PM EST
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $98.62 million as of January 2, 2026. Its market cap has increased by 190.15% in one year.
Market Cap
98.62M
Enterprise Value
161.40M
1-Year Change
190.15%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $98.62M, a decrease of -78.78%. That is a compound annual growth rate of -18.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 94.51M | 5.48% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |